FDA And EMA Collaborate On Advice For Complex Generics And Hybrids
US-EU Pilot Program Will Provide Parallel Scientific Advice For Applicants
The US FDA and EMA have announced a pilot program to provide parallel scientific advice on complex generics and hybrid medicines for prospective applicants, with a goal of harmonization and increased regulatory convergence.
